Literature DB >> 24800686

Vagal intimations for catatonia and electroconvulsive therapy.

Dirk M Dhossche1.   

Abstract

OBJECTIVES: Catatonia is currently viewed as a unique syndrome that consists of specific motor signs responding to benzodiazepines and electroconvulsive therapy (ECT). Advances in catatonia may provide a new window into the mechanism of ECT. Findings on catatonia are updated and related to the mechanism of ECT.
METHODS: Selective literature review.
RESULTS: There are several putative models and mechanisms of catatonia concerning motor circuitry dysfunction, abnormal neurotransmitters, epilepsy, genetic risk factors, and endocrine and immune dysfunction. Fear and vagal nerve models are presented casting catatonia in an evolutionary-based autonomic neural substrate of social behaviors, engagement, and disengagement according to perceived level of danger. Benzodiazepines and ECT are thought to have autonomic and vagal effects.
CONCLUSIONS: Advances in catatonia provide a new window into the mechanism of ECT. Fear and vagal nerve models call for further anatomical, functional, and clinical studies on the vagal nerve and for further studies on the use of anticholinergic medications in catatonia, on vagal function in catatonia, and on the effects of benzodiazepines, ECT, and induced seizures on cholinergic and vagal function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24800686     DOI: 10.1097/YCT.0000000000000134

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  3 in total

1.  Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study.

Authors:  Angelina Kakooza-Mwesige; Dirk M Dhossche; Richard Idro; Dickens Akena; Joyce Nalugya; Benard T Opar
Journal:  BMC Res Notes       Date:  2015-12-28

Review 2.  Review of withdrawal catatonia: what does this reveal about clozapine?

Authors:  Matthew Lander; Tarun Bastiampillai; Jitender Sareen
Journal:  Transl Psychiatry       Date:  2018-07-31       Impact factor: 6.222

3.  Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy.

Authors:  Misako Kanayama; Tsuyoshi Miyaoka; Tomoko Araki; Maiko Hayashida; Sadayuki Hashioka; Jun Horiguchi
Journal:  Case Rep Psychiatry       Date:  2018-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.